GSK3 and p53 - Is there a link in Alzheimer's disease?

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Proctor, Carole J ^a   Gray, Douglas A ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN MDM2; PROTEIN P53;

ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; DNA DAMAGE; ENZYME ACTIVITY; MATHEMATICAL MODEL; MOLECULAR INTERACTION; PROTEIN AGGREGATION;

EID: 77649324578     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-7     Document Type: Article

References (44)

1. The GSK3 hypothesis of Alzheimer's disease. C Hooper R Killick S Lovestone, Journal of Neurochemistry 2008 104 1433 1439 10.1111/j.1471-4159. 2007.05194.x 18088381
2. Requirement for glycogen synthase kinase-3 in cell survival and NF-B activation. KP Hoeflich J Luo EA Rubie M-S Tsao O Jin JR Woodgett, Nature 2000 406 86 90 10.1038/35017574 10894547
3. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. M Pap GM Cooper, J Biol Chem 1998 273 19929 19932 10.1074/jbc.273.32.19929 9685326
4. The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. E Beurel RS Jope, Progress in Neurobiology 2006 79 173 189 10.1016/j.pneurobio.2006.07.006 16935409
5. Does p53 affect organismal aging? LA Donehower, J Cell Physiol 2002 192 23 33 10.1002/jcp.10104 12115733
6. p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells. C Hooper E Meimaridou M Tavassoli G Melino S Lovestone R Killick, Neuroscience Letters 2007 418 34 37 10.1016/j.neulet.2007.03.026 17399897
7. Presenilin-dependent -secretase-mediated control of p53-associated cell death in Alzheimer's disease. C Alves da Costa C Sunyach R Pardossi-Piquard J Sevalle B Vincent N Boyer T Kawarai N Girardot P St George-Hyslop F Checler, J Neurosci 2006 26 6377 6385 10.1523/JNEUROSCI.0651-06.2006 16763046
8. Intracellular A42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. Y Ohyagi H Asahara D-H Chui Y Tsuruta N Sakae K Miyoshi T Yamada H Kikuchi T Taniwaki H Murai K Ikezoe H Furuya T Kawarabayashi M Shoji F Checler T Iwaki T Makifuchi K Takeda J Kira T Tabira, FASEB J 2004 04-2637fje 15548589
9. A inhibits the proteasome and enhances amyloid and tau accumulation. BP Tseng KN Green JL Chan M Blurton-Jones FM LaFerla, Neurobiol Aging 2008 29 1607 1618 10.1016/j.neurobiolaging.2007.04.014 17544172
10. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. S Keck R Nitsch T Grune O Ullrich, J Neurochem 2003 85 115 122 12641733
11. Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. J Eidenmuller T Fath A Hellwig J Reed E Sontag R Brandt, Biochemistry 2000 39 13166 13175 10.1021/bi001290z 11052669
12. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. A Schneider J Biernat M von Bergen E Mandelkow EM Mandelkow, Biochemistry 1999 38 3549 3558 10.1021/bi981874p 10090741
13. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. ML Billingsley RL Kincaid, Biochem J 1997 323 577 591 9169588
14. Proteasomal degradation of tau protein. DC David R Layfield L Serpell Y Narain M Goedert MG Spillantini, Journal of Neurochemistry 2002 83 176 185 10.1046/j.1471-4159.2002.01137.x 12358741
15. Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3beta. GN Bijur RS Jope, J Biol Chem 2001 276 37436 37442 10.1074/jbc.M105725200 11495916
16. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. R Kulikov KA Boehme C Blattner, Mol Cell Biol 2005 25 7170 7180 10.1128/MCB.25.16.7170-7180.2005 16055726
17. The Wnt pool of glycogen synthase kinase 3 is critical for trophic-deprivation-induced neuronal death. V Hongisto JC Vainio R Thompson MJ Courtney ET Coffey, Mol Cell Biol 2008 28 1515 1527 10.1128/MCB.02227-06 18195042
18. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. M Hucka A Finney HM Sauro H Bolouri JC Doyle H Kitano AP Arkin BJ Bornstein D Bray A Cornish-Bowden AA Cuellar S Dronov ED Gilles M Ginkel V Gor II Goryanin WJ Hedley TC Hodgman JH Hofmeyr PJ Hunter NS Juty JL Kasberger A Kremling U Kummer N Le Novère LM Loew D Lucio P Mendes E Minch ED Mjolsness, et al. Bioinformatics 2003 19 524 531 10.1093/bioinformatics/btg015 12611808
19. Tools for the SBML Community. CS Gillespie DJ Wilkinson CJ Proctor DP Shanley RJ Boys TBL Kirkwood, Bioinformatics 2006 22 628 629 10.1093/bioinformatics/btk042 16410323
20. Towards an e-biology of ageing: integrating theory and data. TBL Kirkwood RJ Boys CS Gillespie CJ Proctor DP Shanley DJ Wilkinson, Nat Rev Mol Cell Biol 2003 4 243 249 10.1038/nrm1051 12612643
21. DJ Wilkinson, Stochastic Modelling for Systems Biology Chapman & Hall/CRC Press 2006
22. BASIS. http://www.basis.ncl.ac.uk
23. Biomodels. http://www.ebi.ac.uk/biomodels/
24. BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems. N Le Novere B Bornstein A Broicher M Courtot M Donizelli H Dharuri L Li H Sauro M Schilstra B Shapiro JL Snoep M Hucka, Nucleic Acids Research 2006 34 689 691 10.1093/nar/gkj092 16381960
25. Exact stochastic simulation of coupled chemical reactions. DT Gillespie, The Journal of Physical Chemistry 1977 31 2340 2361 10.1021/j100540a008
26. Explaining oscillations and variability in the p53-Mdm2 system. C Proctor D Gray, BMC Systems Biology 2008 2 75 10.1186/1752-0509-2-75 18706112
27. Oscillations and variability in the p53 system. N Geva-Zatorsky N Rosenfeld S Itzkovitz R Milo A Sigal E Dekel T Yarnitzky Y Liron P Polak G Lahav U Alon, Molecular Systems Biology 2006 2 2006.0033 10.1038/msb4100068 16773083
28. An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline. CJ Proctor M Tsirigotis DA Gray, BMC Systems Biology 2007 1 17 10.1186/1752-0509-1-17 17408507
29. Dynamics of the p53-Mdm2 feedback loop in individual cells. G Lahav N Rosenfeld A Sigal N Geva-Zatorsky AJ Levine MB Elowitz U Alon, Nature Genetics 2004 36 147 150 10.1038/ng1293 14730303
30. Hsp90 maintains the stability and function of the tau phosphorylating kinase GSK3 F Dou X Chang D Ma, International Journal of Molecular Sciences 2007 8 51 60 10.3390/i8010060
31. Glycogen synthase kinase-3 (GSK3) binds to and promotes the actions of p53. P Watcharasit GN Bijur L Song J Zhu X Chen RS Jope, J Biol Chem 2003 278 48872 48879 10.1074/jbc.M305870200 14523002
32. CellDesigner 3.5: A versatile modeling tool for biochemical networks. A Funahashi Y Matsuoka A Jouraku M Morohashi N Kikuchi H Kitano, Proceedings of the IEEE 2008 96 1254 1265 10.1109/JPROC.2008.925458
33. Correlation between elevated levels of amyloid -peptide in the brain and cognitive decline. J Naslund V Haroutunian R Mohs KL Davis P Davies P Greengard JD Buxbaum, JAMA 2000 283 1571 1577 10.1001/jama.283.12.1571 10735393
34. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. J Hardy D Allsop, Trends in pharmacological sciences 1991 12 383 388 10.1016/0165-6147(91)90609-V 1763432
35. Alzheimer disease and cancer. CM Roe MI Behrens C Xiong JP Miller JC Morris, Neurology 2005 64 895 898 15753432
36. Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. T Arai J-P Guo PL McGeer, J Biol Chem 2005 280 5145 5153 10.1074/jbc.M409234200 15542598
37. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. CA Dickey, The Journal of Clinical Investigation 2007 117 648 658 10.1172/JCI29715 17304350
38. Akt and CHIP coregulate tau degradation through coordinated interactions. CA Dickey J Koren Y-J Zhang Y-f Xu UK Jinwal MJ Birnbaum B Monks M Sun JQ Cheng C Patterson RM Bailey J Dunmore S Soresh C Leon D Morgan L Petrucelli, Proceedings of the National Academy of Sciences 2008 105 3622 3627 10.1073/pnas.0709180105 (Pubitemid 351723602)
39. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. L Petrucelli D Dickson K Kehoe J Taylor H Snyder A Grover M De Lucia E McGowan J Lewis G Prihar J Kim WH Dillmann SE Browne A Hall R Voellmy Y Tsuboi TM Dawson B Wolozin J Hardy M Hutton, Hum Mol Genet 2004 13 703 714 10.1093/hmg/ddh083 14962978
40. UniProtKB/Swiss-Prot. http://www.ebi.uniprot.org/index.shtml
41. Systems Biology Ontology. http://www.ebi.ac.uk/sbo/
42. Chemical Entities of Biological Interest database (CHEBI). http://www.ebi.ac.uk/chebi
43. The Gene Ontology. http://www.geneontology.org/
44. Interpro. http://www.ebi.ac.uk/interpro/